Registrars: | Capita Registrars |
CEO: | Christina Coughlin |
CFO: | Tony Peter Gardiner |
Non-Executive Chairman: | Shaun Chilton |
Non-Executive Dir: | Paul Fry, Mark Goldberg, Trevor Nichols |
Address: | Unit 20, Ash Way, Thorp Arch Estate, Wetherby, United Kingdom, LS23 7FA |
Phone: | +44 (0)1904 21 7070 |
Fax: | +44 (0)84 4414 0453 |
Website: | http://www.avacta.com |
Sector: | Pharma and Biotech(LSE) |
Index: | FTSE AIM All-Share |
Domestic Listings: | LSE:E3X1770 |
ISIN: | GB00BYYW9G87 |
Currency | UK Pounds |
Share Price | 46.50p |
Change Today | 2.25p |
% Change | 5.08 % |
52 Week High | 140.00 |
52 Week Low | 39.75 |
Volume | 3,090,174 |
Shares Issued | 369.31m |
Market Cap | £171.73m |
Beta | 1.25 |
RiskGrade | 461 |
Value |
---|
Price Trend |
---|
Income |
---|
Growth |
---|
Strong Buy | 0 |
Buy | 1 |
Neutral | 1 |
Sell | 0 |
Strong Sell | 0 |
Total | 2 |
No dividends found |
Time | Volume / Share Price |
16:37 | 100,000 @ 46.61p |
16:35 | 9,401 @ 46.50p |
16:35 | 6,401 @ 46.50p |
16:35 | 2,076 @ 46.50p |
16:35 | 38 @ 46.50p |
CFO | Tony Peter Gardiner |
CEO | Christina Coughlin |
You are here: research